2023
DOI: 10.1016/j.apsb.2022.09.006
|View full text |Cite
|
Sign up to set email alerts
|

The role of phosphatidylcholine 34:1 in the occurrence, development and treatment of ulcerative colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 53 publications
0
6
0
Order By: Relevance
“…In vivo and in vitro studies have shown that LysoPC can induce the release of pro‐inflammatory cytokines and disrupt the epithelial barrier (Tang et al., 2021). A study revealed a significant reduction in the level of PC lipids in colon organoids of mice with UC, which was found to be closely associated with the progression of the disease (Yu et al., 2023b). Moreover, research has shown that taurocholic acid can lead to the production of hydrogen sulfide and deoxycholic acid, which are genotoxic compounds that can damage intestinal health and even initiate tumors (Ridlon et al., 2016).…”
Section: Resultsmentioning
confidence: 99%
“…In vivo and in vitro studies have shown that LysoPC can induce the release of pro‐inflammatory cytokines and disrupt the epithelial barrier (Tang et al., 2021). A study revealed a significant reduction in the level of PC lipids in colon organoids of mice with UC, which was found to be closely associated with the progression of the disease (Yu et al., 2023b). Moreover, research has shown that taurocholic acid can lead to the production of hydrogen sulfide and deoxycholic acid, which are genotoxic compounds that can damage intestinal health and even initiate tumors (Ridlon et al., 2016).…”
Section: Resultsmentioning
confidence: 99%
“…Phosphatidylcholines have previously been reported to be decreased in the intestinal mucus of patients with ulcerative colitis 55 , 56 . Both upregulation of phosphatidylcholine hydrolyzing enzyme phospholipase A2 and downregulation of phosphatidylcholine synthase have been documented in human patients and rodent models of IBD and were proposed to be underlying mechanisms of phosphatidylcholine-deficiency 57 , 58 . Supplementation of phosphatidylcholine in humans has been shown to have anti-inflammatory effects in patients with IBD 51 , 59 and improve clinical and endoscopic outcomes, histologic activity, and quality of life in patients with ulcerative colitis 59 , 60 .…”
Section: Discussionmentioning
confidence: 99%
“…The metabolic profiles of serum, urine, gut tissues and faecal extracts have been measured in mouse models of ulcerative colitis and patients in previous studies ( Schicho et al, 2010 ; Le Gall et al, 2011 ; Zhang et al, 2013 ). Alterations in lipids (cholesterol, triglycerides, phospholipids and fatty acids), amino acids (tryptophan, phenylalanine, glutamic acid, glutamine, methionine, and homocysteine), ketone bodies (3-hydroxybutyrate), energy metabolites (lactate, pyruvate and metabolites in the TCA cycle), and purines and pyrimidines have been observed in ulcerative colitis ( Shiomi et al, 2011 ; De Preter, 2015 ; LINS et al, 2020 ; Aldars-Garcia et al, 2021 ; Kang et al, 2022 ; Yu et al, 2022 ). In this study, we measured the metabolites in the serum, colon tissue, gut contents and faeces of the colitis mouse model using a UPLC-TOF/MS-based untargeted metabolomics method.…”
Section: Discussionmentioning
confidence: 99%